Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
2.920
-0.090 (-2.99%)
At close: Dec 5, 2025, 4:00 PM EST
2.910
-0.010 (-0.34%)
After-hours: Dec 5, 2025, 6:26 PM EST
Aclaris Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -141.68 | -132.07 | -88.48 | -86.91 | -90.87 | -51.02 | |
| Depreciation & Amortization | 0.5 | 0.81 | 0.86 | 0.8 | 0.92 | 1.32 | |
| Asset Writedown & Restructuring Costs | 86.91 | 86.91 | 6.63 | - | - | - | |
| Stock-Based Compensation | 12.32 | 10.86 | 20.54 | 15.04 | 14.06 | 11.21 | |
| Other Operating Activities | 0.6 | 2.5 | -27.27 | 4.7 | 25.09 | 2.21 | |
| Change in Accounts Receivable | 3.09 | -0.02 | 0.19 | 0.14 | 0.15 | 4.9 | |
| Change in Accounts Payable | 1.51 | -4.19 | -1.47 | 0.37 | 3.66 | -5.22 | |
| Change in Unearned Revenue | -3.53 | 23.93 | - | - | - | - | |
| Change in Other Net Operating Assets | -2.63 | -8.8 | 10.68 | -1.7 | -5.15 | -2.04 | |
| Operating Cash Flow | -42.92 | -20.08 | -78.33 | -67.57 | -52.13 | -38.63 | |
| Capital Expenditures | -0.09 | -0.12 | -1.31 | -0.61 | -0.31 | -0.45 | |
| Sale (Purchase) of Intangibles | -36.64 | -35.81 | - | - | - | - | |
| Investment in Securities | -14 | -33.84 | 47.53 | 13.23 | -167.32 | 6.84 | |
| Investing Cash Flow | -50.73 | -69.77 | 46.22 | 12.63 | -167.63 | 6.39 | |
| Long-Term Debt Issued | - | - | - | - | - | 10.91 | |
| Long-Term Debt Repaid | - | - | - | - | -11.48 | -0.14 | |
| Net Debt Issued (Repaid) | - | - | - | - | -11.48 | 10.78 | |
| Issuance of Common Stock | 80 | 80.03 | 27.63 | 72.9 | 239.66 | 7.81 | |
| Repurchase of Common Stock | -0.62 | -0.41 | -0.1 | -0.03 | -3.12 | - | |
| Other Financing Activities | -8.13 | -5.09 | -0.83 | - | - | -0.21 | |
| Financing Cash Flow | 71.25 | 74.54 | 26.71 | 72.87 | 225.05 | 18.37 | |
| Net Cash Flow | -22.4 | -15.31 | -5.4 | 17.93 | 5.29 | -13.87 | |
| Free Cash Flow | -43.01 | -20.2 | -79.63 | -68.17 | -52.44 | -39.09 | |
| Free Cash Flow Margin | -273.20% | -107.89% | -254.84% | -229.13% | -775.65% | -602.99% | |
| Free Cash Flow Per Share | -0.37 | -0.26 | -1.14 | -1.04 | -0.92 | -0.92 | |
| Levered Free Cash Flow | -58.37 | -59.12 | -37.97 | -39.31 | -28.51 | -18.59 | |
| Unlevered Free Cash Flow | -58.37 | -59.12 | -37.97 | -39.31 | -28.51 | -18.59 | |
| Change in Working Capital | -1.56 | 10.92 | 9.39 | -1.2 | -1.34 | -2.36 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.